Quest Diagnostics Raises 2026 Revenue and Earnings Per Share Guidance
Quest Diagnostics (DGX) has officially raised its full-year 2026 financial outlook following its third-quarter earnings release. The company increased its revenue guidance to a range of $12.065 billion to $12.105 billion, up from the previous projection of $11.95 billion to $12.05 billion. In addition to top-line growth, the diagnostic laboratory provider also boosted its adjusted diluted earnings per share (EPS) expectations. This upward revision signals stronger-than-anticipated operational performance and provides a positive outlook for shareholders regarding the company's profitability heading into the end of the fiscal period.
Tickers: $DGX
Topics: EPS guidance financial outlook revenue guidance
Read the full article at Seeking Alpha
Part of the story Elevance Raises 2026 Earnings Guidance Following Strong Q3 Performance (3 articles)